Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws.
Thursday, March 5
Trending
- PRIME MINISTER DREW ENGAGES UNIVERSITY OF GHANA LEADERSHIP TO ADVANCE EDUCATION AND RESEARCH COOPERATION
- PRIME MINISTER DREW SIGNS MOU ESTABLISHING POLITICAL CONSULTATION MECHANISM WITH THE REPUBLIC OF GHANA
- PRIME MINISTER DREW RECEIVES FULL STATE HONOURS AT JUBILEE HOUSE DURING OFFICIAL VISIT TO THE REPUBLIC OF GHANA
- PRIME MINISTER, THE HONOURABLE DR. TERRANCE DREW, ARRIVES IN GHANA FOR OFFICIAL STATE VISIT
- Embassy of Saint Kitts and Nevis Unveils White-Tailed Deer at 2026 Taiwan Lantern Festival
- Clean Energy Push Positioned to Strengthen St. Kitts and Nevis Economy – IMF
- IMF Acknowledges Tourism Recovery and Positive Growth Outlook for St. Kitts and Nevis
- Federation Marks Major Advancement in National Sargassum Management Capacity

